65,437 trials
AML · ALL · Undifferentiated Leukemia
Primary: Percentage of Participants With Grade III-IV Acute GVHD by Day 100. — 10 percentage of participants
Post Partum
Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants
HIV · HIV Infections · Pregnancy
Primary: Predose (Trough) Plasma Concentration (C0h) — 3608; 491.4; 2481; 147 nanogram per milliliter (ng/mL)
Hepatitis C Virus Infection
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks After Discontinuation of Therapy (SVR12) — 87.9; 93.3; 100.0; 96.6 percentage of participants
Meralgia Paresthetica
Primary: Anesthesia Related Time — 554; 480 seconds — p=0.05
Contraception
Primary: Pregnancy Reported as Pearl Index — 8.19; 6.80 Pearl Index
Cervical Carcinoma · Cervical Intraepithelial Neoplasia Grade 2/3 · Stage 0 Cervical Cancer
Primary: Histologic Regression — 40; 34.1 percentage of participants
Colorectal Cancer
Primary: Number of Participants Reporting Preferred Screening Type as Reported by Chart Audits — 111; 99 participants
Pregnancy Termination in Second Trimester
Primary: Visual Analog Scale (VAS) Score for Maximum Procedural Pain — 54.1; 34.0 units on a scale
Alcohol Concentration Values · Alcohol Intoxication
Primary: Percent Alcohol Concentration Measured by Breathalyzer — 0.099; 0.086; 0.099; 0.099 percent Breathalyzed alcohol content — p=<0.0001
Chronic Hepatitis C · Hepatitis C Virus · Genotype 3 Hepatitis C Virus
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12): Noninferiority of Arm A to Arm B — 95.3; 96.5 percentage of participants
Sleep Apnea Syndromes · Oxidative Stress · Cardiovascular Diseases
Primary: F2-isoprostanes/Cr — -0.02; -0.08 ng/mg — p=0.38
Differentiated Thyroid Gland Carcinoma · Recurrent Thyroid Gland Carcinoma · Refractory Thyroid Gland Carcinoma
Primary: Objective Response Rate, Assessed Using the Response Evaluation Criteria in Solid Tumors (RECIST) — 9; 7 Participants — p=<0.10
Psoriatic Arthritis
Primary: Percentage of Participants Meeting American College of Rheumatology Response Criteria Greater Than or Equal to (≥) 20% (ACR20): Month 3 — 49.62; 46.97; 23.66 Percentage…
Mucopolysaccharidosis Type I · Mucopolysaccharidosis Type II · Mucopolysaccharidosis Type VI
Primary: Children's Health Questionnaire - Parent Form 50 Bodily Pain Standardized Score — 1.4; 1.0 units on a scale